This is a pilot study, randomized, double-blind, parallel group comparison of two iodinated
contrast agents used during percutaneous coronary intervention (PCI). All patients enrolled
must have normal eGFR. Statistical summaries will be presented to analyse the various
laboratory tests for the two groups.